PhytoHealth Corporation (TWSE: 4108)
Health Care · Pharmaceuticals · TW
NT$11.35
+0.89% today · -13.0% 1Y
PhytoHealth Corporation (TWSE: 4108) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.79M and employs 84 people.
Over the last twelve months the share price has lost 13.0%, trading between 10.70 and 17.90.
Tweenvest scores PhytoHealth Corporation across four factors: quality 50/100, value 68/100, growth 0/100. Its strongest factor is value.
4108 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.79M
- Revenue (TTM)
- $4.51M
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 0.35
- 52-week high
- NT$17.90
- 52-week low
- NT$10.70
- Avg volume (3M)
- —
- Shares outstanding
- 198.62M
- Employees
- 84
- Next earnings
- —
About PhytoHealth Corporation
Established in 1998 and headquartered in Taipei, Taiwan, PhytoHealth Corporation specializes in the research, development, production, and commercialization of a diverse portfolio including pharmaceutical products, cosmetic lines, specific over-the-counter medications (Class B), and nutritional supplements. Their prominent offerings feature the PG2 Lyophilized injection, specifically designed to alleviate cancer-related fatigue. The company also markets EnerCharge, available both as a formula to boost physical vigor and maintain mental alertness, and as an energy beverage. Another notable product is ReyeasCleanse health food capsules. Furthermore, PhytoHealth extends its expertise to precision medical devices, specialized diagnostic software, and licensing services for computer-aided diagnostic systems.
- ISIN
- TW0004108006
- Founded
- 1998
- Listed since
- Jul 16, 2008
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.90 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.03 | -1.14% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.57 | -1.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.79% |
Figures last refreshed Aug 18, 2026.